Australia markets closed

Journey Medical Corporation (DERM)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
3.4500-0.1700 (-4.70%)
At close: 04:00PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-4,159
-3,853
-29,628
-43,994
5,283
Depreciation & amortisation
3,600
3,855
4,365
2,560
1,516
Deferred income taxes
-
-
0
1,566
-335
Stock-based compensation
3,366
2,606
4,425
2,466
153
Change in working capital
-5,744
-1,655
6,187
14,709
-2,232
Accounts receivable
17,502
12,551
-5,380
768
-5,022
Inventory
2,698
3,953
1,744
-8,458
-547
Accounts payable
-28,315
-18,421
14,343
20,388
-152
Other working capital
1,177
240
-33,534
-12,181
3,932
Other non-cash items
656
709
833
20,017
698
Net cash provided by operating activities
1,177
5,240
-13,534
-2,181
5,132
Cash flows from investing activities
Investments in property, plant and equipment
-
-5,000
-20,000
-10,000
-1,200
Other investing activities
-
-
-20,000
-
-
Net cash used for investing activities
0
-5,000
-20,000
-10,000
-1,200
Cash flows from financing activities
Debt repayment
-24,000
-51,948
-7,864
-11,488
-500
Common stock issued
5,978
4,494
0
32,536
0
Other financing activities
-
-471
-585
-3,546
-
Net cash used provided by (used for) financing activities
-3,219
-4,804
16,456
53,016
-487
Net change in cash
-2,042
-4,564
-17,078
40,835
3,445
Cash at beginning of period
26,099
32,003
49,081
8,246
4,801
Cash at end of period
24,057
27,439
32,003
49,081
8,246
Free cash flow
Operating cash flow
1,177
5,240
-13,534
-2,181
5,132
Capital expenditure
-
-5,000
-20,000
-10,000
-1,200
Free cash flow
1,177
240
-33,534
-12,181
3,932